What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.

Company

Jan. 25

Weekly Gain

My Watchlist

Netflix (NASDAQ:NFLX)

$169.56

71%

Add

ACADIA Pharmaceuticals (NASDAQ:ACAD)

$6.15

19%

Add

Sarepta Therapeutics (NASDAQ:SRPT)

$27.91

16%

Add

Green Mountain Coffee (NASDAQ:GMCR)

$46.31

14%

Add

Research In Motion (NASDAQ:BBRY)

$17.54

11%

Add

Source: Barron's.

Netflix was last week's biggest winner, soaring 71% after stunning investors with a healthy quarterly profit in its latest quarter. The leading video provider also closed out the year with healthy subscriber growth and a robust outlook for the current quarter.

ACADIA inched higher every single day last week. Jim Cramer's blessing along the way only helped the biotech. "You want to buy, buy, buy ACADIA," Cramer said during Tuesday night's Mad Money lightning round, echoing the sentiment of bulls who are hopeful over the company's promising Parkinson's treatment.

Sarepta Therapeutics moved up after Cowen initiated coverage on the biotech company with an "outperform" rating. Sarepta's treatment for Duchenne muscular dystrophy has performed well through its early clinical trials.

Green Mountain Coffee Roasters was also percolating nicely last week. Shares of the company behind the Keurig single-cup brewer posted double-digit gains after receiving a favorable report from a KeyBanc analyst.

Research In Motion rallied after its CEO told a German newspaper that the BlackBerry maker may be open to licensing its mobile operating system. RIM also revealed by the end of the week that it will have an ad in next weekend's Super Bowl game.

Longtime Fool contributor Rick Aristotle Munarriz owns shares of Netflix and Green Mountain Coffee Roasters. The Motley Fool recommends Green Mountain Coffee Roasters and Netflix and owns shares of Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.